PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Who Will Win the Race to Treat NASH?

Ferring: The Quiet Company

Real-World Evidence: From Volume to Value

EPL 2017

Pharm Exec’s Emerging Pharma Leaders 2017

Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.
... /Read more/

Executive Profile

TESARO: Setting New Benchmarks in Patient-Centricity

TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
... /Read more/

Opinion

How Pharmas, Payers, and Providers Can Meet the ‘Triple Aim’

Today’s model requires a fourth partner—the systems integrator, writes Adam Nelson.
... /Read more/

R&D

Can Streamlined R&D Reduce Drug Prices?

FDA seeks to de-risk research and promote competition to achieve savings for patients and plans.
... /Read more/

Real-World Evidence

The Future of Real-World Studies

What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
... /Read more/

Launching into Value: Pharma's Quest to Align Drug Prices with Outcomes
On Demand

Learn more

Calendar

/ 12^th Annual Value-Based Oncology Management 10/24-10/25 /

/ MedComm 2017 10/26-10/27 /

/ EU Life Sciences GDPR Bootcamp 11/14 /

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com